This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Adient (ADNT) Q1 Earnings Beat, Sales Fall Shy of Estimates
by Zacks Equity Research
Adient (ADNT) surpasses fiscal first-quarter 2021 earnings mark on higher-than-anticipated EBITDA across each of the segments.
Ride Market Rally With High-Beta ETFs & Stocks
by Sweta Killa
While every corner of the market is enjoying this ascent, high-beta ETFs and stocks seem a perfect bet at present.
Lear (LEA) Q4 Earnings and Sales Trump Estimates, Up Y/Y
by Zacks Equity Research
Lear (LEA) envisions full-year 2021 net sales between $19.8 billion and $20.8 billion.
Adient (ADNT) Beats Q1 Earnings Estimates
by Zacks Equity Research
Adient (ADNT) delivered earnings and revenue surprises of 80.00% and -1.78%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Cummins' (CMI) Q4 Earnings & Sales Beat Estimates, Rise Y/Y
by Zacks Equity Research
Cummins projects full year 2021 revenues to be up 8-12% and EBITDA to be in the range of 15-15.5% of sales.
Meritor (MTOR) Beats on Q1 Earnings & Sales, Raises FY21 View
by Zacks Equity Research
Meritor (MTOR) projects sales in the range of $3.65-$3.8 billion for fiscal 2021, up from the prior estimate of $3.1-$3.35 billion.
New Strong Buy Stocks for February 2nd
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:
Gentex (GNTX) Q4 Earnings Beat, '21 Sales Outlook Upbeat
by Zacks Equity Research
Gentex (GNTX) envisions net sales in the band of $1.94-2.02 billion for 2021, indicating an increase from 2020 revenues of $1.68 billion.
5 Promising Price-to-Book Value Stocks to Buy Now
by Kinjel Shah
P/B ratio is emerging as a convenient tool to identify low-priced stocks that have high growth prospects.
ADNT vs. SHYF: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
ADNT vs. SHYF: Which Stock Is the Better Value Option?
Zacks.com featured highlights include: Alexion Pharmaceuticals, Adient, Affiliated Managers Group and General Motors
by Zacks Equity Research
Zacks.com featured highlights include: Alexion Pharmaceuticals, Adient, Affiliated Managers Group and General Motors
4 Promising Price-to-Book Value Stocks to Buy Now
by Kinjel Shah
P/B ratio is emerging as a convenient tool to identify low-priced stocks that have high growth prospects.
Adient (ADNT) Upgraded to Strong Buy: Here's What You Should Know
by Zacks Equity Research
Adient (ADNT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
New Strong Buy Stocks for January 8th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:
Why Is Adient (ADNT) Up 3.3% Since Last Earnings Report?
by Zacks Equity Research
Adient (ADNT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why Adient (ADNT) Stock Might be a Great Pick
by Zacks Equity Research
Adient (ADNT) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
4 Auto Stocks Poised to Continue Their Winning Streaks in 2021
by Pooja Dhona
The auto sector is projected to witness year-on-year earnings growth of 58% in 2021. Amid the upbeat scenario, stocks like TSLA, MGA, CMI and ADNT are set to fly high next year.
The Zacks Analyst Blog Highlights: RYAM, CVGI, Apergy, Adient and Michaels
by Zacks Equity Research
The Zacks Analyst Blog Highlights: RYAM, CVGI, Apergy, Adient and Michaels
What Makes Adient (ADNT) a Strong Momentum Stock: Buy Now?
by Zacks Equity Research
Does Adient (ADNT) have what it takes to be a top stock pick for momentum investors? Let's find out.
Vaccines to Fuel Santa Claus Rally: 5 Stock Picks
by Sweta Killa
With only eight trading days left this year, markets are bracing for the so-called Santa Claus rally.
Is Adient (ADNT) Outperforming Other Auto-Tires-Trucks Stocks This Year?
by Zacks Equity Research
Is (ADNT) Outperforming Other Auto-Tires-Trucks Stocks This Year?
Auto Stock Roundup: GM-NKLA Revised Deal, ADNT Q4 Earnings & More
by Rimmi Singhi
Amid allegations against Nikola (NKLA), General Motors (GM) would no longer manufacture the Badger truck for the electric truck startup. Meanwhile, Adient (ADNT) tops Q4 earnings estimates.
Is Adient (ADNT) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Are You Looking for a Top Momentum Pick? Why Adient (ADNT) is a Great Choice
by Zacks Equity Research
Does Adient (ADNT) have what it takes to be a top stock pick for momentum investors? Let's find out.
Adient (ADNT) Moves to Buy: Rationale Behind the Upgrade
by Zacks Equity Research
Adient (ADNT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).